Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year




Total Raised


Date of IPO


Market Cap


Stock Price


About Tyra Biosciences

Tyra Biosciences (NASDAQ: TYRA) develops specific compounds that target drug-resistant cancer cells and populations.

Tyra Biosciences Headquarter Location

2656 State Street

Carlsbad, California, 92008,

United States

Latest Tyra Biosciences News

Tyra Biosciences, Inc. : Von Jefferies & Co. auf neutral herabgestuft

Nov 8, 2021

( Jefferies & Co. gibt eine neutrale Bewertung ab. Der Zielpreis wurde angehoben und liegt nun bei 31 USD gegenüber zuvor 19 USD.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Tyra Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tyra Biosciences is included in 2 Expert Collections, including Biopharma Tech.


Biopharma Tech

5,238 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Tyra Biosciences Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Tyra Biosciences Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.